HUT74638A - New emulsion formulation - Google Patents

New emulsion formulation Download PDF

Info

Publication number
HUT74638A
HUT74638A HU9600900A HU9600900A HUT74638A HU T74638 A HUT74638 A HU T74638A HU 9600900 A HU9600900 A HU 9600900A HU 9600900 A HU9600900 A HU 9600900A HU T74638 A HUT74638 A HU T74638A
Authority
HU
Hungary
Prior art keywords
oil
formulation
emulsion
stabilizing surfactant
water
Prior art date
Application number
HU9600900A
Other languages
English (en)
Hungarian (hu)
Other versions
HU9600900D0 (en
Inventor
Stefan Lundquist
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of HU9600900D0 publication Critical patent/HU9600900D0/hu
Publication of HUT74638A publication Critical patent/HUT74638A/hu

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Nanotechnology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
HU9600900A 1993-10-07 1994-10-05 New emulsion formulation HUT74638A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9303281A SE9303281D0 (sv) 1993-10-07 1993-10-07 New formulation

Publications (2)

Publication Number Publication Date
HU9600900D0 HU9600900D0 (en) 1996-05-28
HUT74638A true HUT74638A (en) 1997-01-28

Family

ID=20391342

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9600900A HUT74638A (en) 1993-10-07 1994-10-05 New emulsion formulation

Country Status (31)

Country Link
US (2) US5843465A (is)
EP (1) EP0722316B1 (is)
JP (1) JPH09504279A (is)
CN (1) CN1134663A (is)
AT (1) ATE189119T1 (is)
AU (1) AU701512B2 (is)
BR (1) BR9407748A (is)
CA (1) CA2172143A1 (is)
CZ (1) CZ94396A3 (is)
DE (1) DE69422818T2 (is)
DK (1) DK0722316T3 (is)
EE (1) EE03235B1 (is)
EG (1) EG20540A (is)
ES (1) ES2145158T3 (is)
FI (1) FI961525A0 (is)
GR (1) GR3033255T3 (is)
HK (1) HK1009257A1 (is)
HU (1) HUT74638A (is)
IL (1) IL111131A (is)
IS (1) IS4209A (is)
MA (1) MA23344A1 (is)
NO (1) NO961363L (is)
NZ (1) NZ274583A (is)
PL (1) PL313767A1 (is)
PT (1) PT722316E (is)
SE (1) SE9303281D0 (is)
SG (1) SG47896A1 (is)
SK (1) SK39396A3 (is)
TN (1) TNSN94099A1 (is)
WO (1) WO1995009609A1 (is)
ZA (1) ZA947351B (is)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
US6054421A (en) * 1997-09-23 2000-04-25 Scimed Life Systems, Inc. Medical emulsion lubricant
US6281175B1 (en) 1997-09-23 2001-08-28 Scimed Life Systems, Inc. Medical emulsion for lubrication and delivery of drugs
US20020086857A1 (en) * 2000-09-15 2002-07-04 Mcdonald George B. Method of long-term treatment of graft-versus-host disease using topical active corticosterioids
US20100184732A1 (en) * 2000-09-15 2010-07-22 Mcdonald George Method of long-term treatment of graft-versus-host disease using topical active corticosteroids
DE10059430A1 (de) * 2000-11-30 2002-06-06 Cognis Deutschland Gmbh Feinteilige Emulsionen
CA2449856C (en) 2001-06-15 2009-03-10 Cornerstone Pharmaceuticals Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cells
DK1416917T3 (da) * 2001-08-06 2007-09-17 Astrazeneca Ab Vandig dispersion, der omfatter stabile nanopartikler af et vanduoplöseligt aktivt stof og en excipiens som middellangkædede triglycerider (MCT)
TWI248159B (en) * 2002-01-25 2006-01-21 Nanya Technology Corp Manufacturing method for shallow trench isolation with high aspect ratio
GB0216700D0 (en) * 2002-07-18 2002-08-28 Astrazeneca Ab Process
US7544674B2 (en) 2002-10-25 2009-06-09 Galderma S.A. Topical skin care composition
US8685428B2 (en) * 2002-12-10 2014-04-01 Advanced Cardiovascular Systems, Inc. Therapeutic composition and a method of coating implantable medical devices
GB0230087D0 (en) * 2002-12-24 2003-01-29 Astrazeneca Ab Therapeutic agents
GB0230088D0 (en) * 2002-12-24 2003-01-29 Astrazeneca Ab Therapeutic agents
GB0302671D0 (en) * 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
GB0302673D0 (en) * 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
GB0302672D0 (en) * 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
US7323206B1 (en) 2003-03-04 2008-01-29 B. Braun Medical Inc. Reagents and methods for all-in-one total parenteral nutrition for neonates and infants
GB0314057D0 (en) * 2003-06-18 2003-07-23 Astrazeneca Ab Therapeutic agents
JP2006527770A (ja) * 2003-06-18 2006-12-07 アストラゼネカ アクチボラグ Ｃｂ１モジュレーターとしての２−置換５，６−ジアリール−ピラジン誘導体
GB0314261D0 (en) * 2003-06-19 2003-07-23 Astrazeneca Ab Therapeutic agents
US20070140999A1 (en) * 2003-07-18 2007-06-21 Hill Dermaceuticals, Inc. Topical skin care composition containing refined peanut oil
US7169401B2 (en) * 2003-07-18 2007-01-30 Hill Dermaceuticals, Inc. Topical skin care composition containing refined peanut oil
US20060099173A1 (en) * 2003-10-24 2006-05-11 Nancy Puglia Topical skin care composition
US20070207107A1 (en) * 2006-03-03 2007-09-06 Gareth Winckle Silicone based emulsions for topical drug delivery
US8473062B2 (en) 2008-05-01 2013-06-25 Autonomic Technologies, Inc. Method and device for the treatment of headache
US8412336B2 (en) 2008-12-29 2013-04-02 Autonomic Technologies, Inc. Integrated delivery and visualization tool for a neuromodulation system
US8494641B2 (en) 2009-04-22 2013-07-23 Autonomic Technologies, Inc. Implantable neurostimulator with integral hermetic electronic enclosure, circuit substrate, monolithic feed-through, lead assembly and anchoring mechanism
US9320908B2 (en) 2009-01-15 2016-04-26 Autonomic Technologies, Inc. Approval per use implanted neurostimulator

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4073943A (en) * 1974-09-11 1978-02-14 Apoteksvarucentralen Vitrum Ab Method of enhancing the administration of pharmalogically active agents
AT358530B (de) * 1978-04-25 1980-09-10 Plc Pharma Licences Stabilisierungsverfahren
JPS58222014A (ja) * 1982-06-18 1983-12-23 Taisho Pharmaceut Co Ltd プロスタグランジンｅ↓１脂肪乳剤
US4622219A (en) * 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic
JPH0818989B2 (ja) * 1984-01-12 1996-02-28 株式会社ミドリ十字 脂肪乳剤中のプロスタグランジンの安定化方法
JPH0647533B2 (ja) * 1984-08-10 1994-06-22 裕 水島 ４−ビフエニリル酢酸系化合物含有脂肪乳剤
US4760096A (en) * 1985-09-27 1988-07-26 Schering Corporation Moisturizing skin preparation
DE3623376A1 (de) * 1986-07-11 1988-01-21 Behringwerke Ag Pharmazeutische formulierung und verfahren zu deren herstellung
GB8919172D0 (en) * 1989-08-23 1989-10-04 Univ Nottingham Useful composition
JP2785981B2 (ja) * 1989-11-20 1998-08-13 株式会社資生堂 乳化組成物
US5089268A (en) * 1990-05-02 1992-02-18 Katz David P Egg phosphatide lipid emulsions altered for a specific therapeutic fatty acid composition

Also Published As

Publication number Publication date
HU9600900D0 (en) 1996-05-28
EP0722316B1 (en) 2000-01-26
CZ94396A3 (en) 1996-06-12
NO961363D0 (no) 1996-04-02
IS4209A (is) 1995-04-08
EG20540A (en) 1999-07-31
HK1009257A1 (en) 1999-05-28
EE03235B1 (et) 1999-12-15
ES2145158T3 (es) 2000-07-01
IL111131A (en) 1999-09-22
NZ274583A (en) 1998-01-26
ZA947351B (en) 1995-04-10
PT722316E (pt) 2000-06-30
AU7866794A (en) 1995-05-01
BR9407748A (pt) 1997-11-11
FI961525A (fi) 1996-04-04
AU701512B2 (en) 1999-01-28
EP0722316A1 (en) 1996-07-24
ATE189119T1 (de) 2000-02-15
TNSN94099A1 (fr) 1995-04-25
MA23344A1 (fr) 1995-07-01
NO961363L (no) 1996-04-02
SG47896A1 (en) 1998-04-17
US5660837A (en) 1997-08-26
SK39396A3 (en) 1997-02-05
JPH09504279A (ja) 1997-04-28
IL111131A0 (en) 1994-12-29
CN1134663A (zh) 1996-10-30
CA2172143A1 (en) 1995-04-13
US5843465A (en) 1998-12-01
WO1995009609A1 (en) 1995-04-13
DE69422818T2 (de) 2000-07-27
FI961525A0 (fi) 1996-04-04
PL313767A1 (en) 1996-07-22
DE69422818D1 (de) 2000-03-02
DK0722316T3 (da) 2000-06-13
GR3033255T3 (en) 2000-09-29
SE9303281D0 (sv) 1993-10-07

Similar Documents

Publication Publication Date Title
HUT74638A (en) New emulsion formulation
JP5688406B2 (ja) 抗真菌医薬組成物
KR100861820B1 (ko) 미생물 특성이 증진된 프로포폴 제제
GB2559774A (en) Oral cannabinoid formulations
JP5113323B2 (ja) ジクロフェナクナトリウムとβ−シクロデキストリンとを有する注入可能薬学組成物
HUT77283A (hu) Egyszerű összetételű, a hatóanyagot biológiailag jól hozzáférhetően tartalmazó, orális alkalmazásra szánt új ciklosporinkészítmény és eljárás az előállítására
EP1238677A2 (en) Parenteral fat emulsions comprising edetate as preservative
JP6348567B2 (ja) マイクロエマルジョン局所送達プラットフォーム
EP1349545B1 (en) Pharmaceutical compositions of fenretinide having increased bioavailability and methods of using the same
HU223142B1 (hu) Rövid hatóidejű dihidro-piridin típusú vérnyomáscsökkentőt tartalmazó gyógyszerészeti emulzió
JP2016512562A5 (is)
TWI700087B (zh) 癸二醯雙那布扶林酯之緩釋藥物製劑
KR20200128407A (ko) 네비볼롤을 포함하는 약제학적 조성물
US20060257434A1 (en) Production of emulsions of pharmaceutical compositions
JP2021095420A (ja) エピナスチン又はその塩を含有する水性医薬組成物
US5554650A (en) Antiphlogistic, analgesic, antipyretic injection preparation
US7888392B2 (en) Ointment
JP2023531725A (ja) ジクアホソルを含む点眼組成物
KR102556874B1 (ko) 비스포스포네이트 및 콜레칼시페롤을 함유하는 경구용 에멀젼 조성물 및 그 제조방법
US20240156829A1 (en) Stable Antiemetic Emulsions for Parenteral Administration
CN103025323A (zh) 难溶性三环衍生物化合物的溶解度得到提高的药学组合物
JP2013001700A (ja) プロポフォール含有水中油型エマルション組成物
EP3888635A1 (en) Drug delivery platform using w/o/w-type triolein emulsion promotive of blood-brain barrier opening
JP2001226257A (ja) 溶液製剤
EP1660522A2 (en) Pharmaceutical composition with increased bioavailability suitable for the administration of oral retroviral protease inhibitors. process for preparing a concentrate pharmaceutical composition comprising a retroviral protease inhibitor

Legal Events

Date Code Title Description
DFD9 Temporary protection cancelled due to non-payment of fee